Barrett's Oesophagus: Pathophysiology, Diagnosis, and Management

REFERENCES

• Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287–9.
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology 1995;109:1541–46.
   PubMed Web of Science ®Google Scholar
• Barrett NR. Chronic peptic ulcer of the oesophagus and ‘oesophagitis’. Br J Surg 1950;38:175–82.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasie, and Norman Barrett. Gastroenterology 1996;110:614–21.
   PubMed Web of Science ®Google Scholar
• McClave SA, Worth Boyce H Jr, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987;33:413–6.
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249–56.
   Google Scholar
• Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett’s esophagus) have any real value? Endoscopy 1995;27:19–26.
   PubMed Web of Science ®Google Scholar
• Clark GWB, Ireland AP, DeMeester TR. Dysplasia in Barrett’s esophagus: diagnosis, surveillance and treatment. Dig Dis 1996; 14:213–27.
   PubMed Web of Science ®Google Scholar
• Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, ‘carditis,’ and Barrett’s esophagus, and sequelea of therapy. Am J Surg Pathol 1996;S31–51.
   Google Scholar
• Weinstein WM, Ippoliti AF. The diagnosis of Barrett’s esophagus: goblets, goblets, goblets. Gastrointest Endosc 1996; 44:91–5.
   PubMedGoogle Scholar
• Spechler SJ, Goyal RK. Barrett’s esophagus. N Engl J Med 1986;315:362–71.12. Monnier P, Fontolliet C, Savary M, Ollyo JB. Barrett’s oesophagus or columnar epithelium of the lower oesophagus. Baillieres Clin Gastroenterol 1987;1: 769–89.
   Google Scholar
• Miwa K, Sahara H, Segawa M, Kinami S, Sato K, Miyazaki I, et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996;67:269–74.
   PubMed Web of Science ®Google Scholar
• Attwood SEA, DeMeester TR, Bremner CG, Barlow AP, Hinder RA. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett’s columnar-lined lower esophagus. Surgery 1989;106:764–70.
   Google Scholar
• Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897–907.
   Google Scholar
• Savarino V, Mela GS, Zentilin P, Mele MR, Mansi C, Remagnino AC, et al. Time pattern of gastric acidity in Barrett’s esophagus. Dig Dis Sci 1996;41:1379–83.
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918–22.
   Google Scholar
• Winters C Jr, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, et al. Barrett’s esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118–24.
   PubMedGoogle Scholar
• Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 1985;313:857–9.
   Google Scholar
• Menke-Pluymers MB, Hop WC, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155–8.
   Google Scholar
• Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagastric junction. Gastroenterology 1993;104:510–3.
   Google Scholar
• Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993;270: 1320.
   Google Scholar
• Clark GWB, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609–14.
   PubMed Web of Science ®Google Scholar
• Wright TA, Gray MR, Morris AI, Gilmore IT, Ellis A, Smart HL, et al. Cost effectiveness of detecting Barrett’s cancer. Gut 1996;39:574–9.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533–6.
   Google Scholar
• Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett’s esophagus. Cancer 1991;69:8–16.
   Google Scholar
• Haggitt RC. Barrett’s esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982–93.
   PubMed Web of Science ®Google Scholar
• Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, et al. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 1988;19:166–78.
   Google Scholar
• Menke-Pluymers MBE, Mulder AH, Hop WC, van Blankenstein M, Tilanus HW. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett’s oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994;35:1348–51.
   Google Scholar
• Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett’s oesophagus. J Pathol 1995;175: 175–80.
   Google Scholar
• Menke-Pluymers MBE. Risk factors for neoplastic progression in Barrett’s mucosa. Eur J Surg Oncol 1996;22:311–6.
   PubMedGoogle Scholar
• Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett’s oesophagus. Does it help? J Thorac Cardiovasc Surg 1993;105:383–8.
   PubMed Web of Science ®Google Scholar
• Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett’s esophagus. Am J Gastroenterol 1988;83:291–4.
   PubMed Web of Science ®Google Scholar
• Provenzale D, Kemp JA, Arora S, Wong JB. A guide for surveillance of patients with Barrett’s esophagus. Am J Gastroenterol 1994;89:670–80.
   PubMedGoogle Scholar
• Van der burgh A, Dees J, Hop WCJ, van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut 1996;39:5–8.
   PubMed Web of Science ®Google Scholar
• Spechler SJ, Robbins AH, Bloomfield RH, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett’s esophagus: an overrated risk? Gastroenterology 1984;87:927–33.
   PubMed Web of Science ®Google Scholar
• Sampliner RE, Garewal HS, Fennerty MB, Aickin M. Lack of impact of therapy on extent of Barrett’s esophagus in 67 patients. Dig Dis Sci 1990;35:93–6.
   PubMed Web of Science ®Google Scholar
• Spechler SJ. Comparison of medical and surgical therapy for complicated gastroesophageal reflux in veterans. N Engl J Med 1992;326:786–92.
   PubMed Web of Science ®Google Scholar
• Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett’s oesophagus after antireflux surgery. Br J Surg 1995;82:806–10.
   PubMedGoogle Scholar
• Ortiz A, Martinez de Haro LF, Parrilla P, Morales G, Molina J, Bermejo J, et al. Conservative treatment versus antireflux surgery in Barrett’s oesophagus: long-term results of a prospective study. Br J Surg 1996;83:274–8.
   PubMed Web of Science ®Google Scholar
• Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate highgrade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterology 1993;105:40–50.
   PubMed Web of Science ®Google Scholar
• Cameron AJ, Carpenter HA. Barrett’s oesophagus, high grade dysplasia and early adenocarcinoma. Comparison of endoscopic biopsy and surgical pathology findings. Gut 1996;38 Suppl 1: T92.
   Google Scholar
• Fleischer De Wang GQ, Dawsey SM, Tio TL, Kidwell JA, Zhoe B, et al. Endoscopic therapy for esophageal dysplasia and early esophageal cancer in Linxian, China. Implications for the United States. Gastrointest Endosc 1997;45:AB68.
   Google Scholar
• Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett’s esophageal epithelium. Gastroenterology 1993;104: 1686–91.
   Google Scholar
• Sampliner RE, Hixson LJ, Fennerty B, Garewal HS. Regression of Barrett’s esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993;38:365–8.
   PubMed Web of Science ®Google Scholar
• Van Hillegersberg R, Kort WJ, Wilson JHP. Current status of photodynamic therapy in oncology. Drugs 1994;48:510–27.
   Google Scholar
• Overholt BF, Panjehpour M. Barrett’s esophagus: photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial esophageal cancer. Gastrointest Endosc 1995;42:64–9.
   PubMed Web of Science ®Google Scholar
• Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584–5.
   PubMed Web of Science ®Google Scholar
• Overholt BF, Panjehpour M. Photodynamic therapy in Barrett’s esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995;11:372–6.
   PubMedGoogle Scholar
• Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett’s esophagus. Gastrointest Endosc 1995;42:59–63.
   PubMed Web of Science ®Google Scholar